US Patent Issued to UNIVERSITE DE STRASBOURG, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) on May 20 for "Peptides for treatment and prevention of diabetes and associated disorders" (French Inventor)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,556, issued on May 20, was assigned to UNIVERSITE DE STRASBOURG (Strasbourg, France) and INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris).

"Peptides for treatment and prevention of diabetes and associated disorders" was invented by Vincent Marion (Lipsheim, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to peptides for the treatment of diabetes and associated disorders."

The patent was filed on Dec. 20, 2019, under Application No. 17/415,796.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=...